[Federal Register Volume 75, Number 109 (Tuesday, June 8, 2010)]
[Notices]
[Page 32506]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-13751]



-----------------------------------------------------------------------



DEPARTMENT OF JUSTICE



Drug Enforcement Administration




Manufacturer of Controlled Substances; Notice of Registration



    By Notice dated December 1, 2009, and published in the Federal 

Register on December 11, 2009 (74 FR 65789), Cedarburg Pharmaceuticals, 

Inc., 870 Badger Circle, Grafton, Wisconsin 53024, made application by 

renewal to the Drug Enforcement Administration (DEA) to be registered 

as a bulk manufacturer of the basic classes of controlled substances 

listed in schedules I and II:



------------------------------------------------------------------------

                    Drug                               Schedule

------------------------------------------------------------------------

Tetrahydrocannabinols (7370)...............  I

Dihydromorphine (9145).....................  I

Dihydrocodeine (9120)......................  II

Oxycodone (9143)...........................  II

Hydromorphone (9150).......................  II

Hydrocodone (9193).........................  II

Remifentanil (9739)........................  II

Sufentanil (9740)..........................  II

Fentanyl (9801)............................  II

------------------------------------------------------------------------



    The company plans to manufacture the listed controlled substances 

in bulk for distribution to its customers.

    No comments or objections have been received. DEA has considered 

the factors in 21 U.S.C. 823(a) and determined that the registration of 

Cedarburg Pharmaceuticals, Inc., to manufacture the listed basic 

classes of controlled substances is consistent with the public interest 

at this time. DEA has investigated Cedarburg Pharmaceuticals, Inc., to 

ensure that the company's registration is consistent with the public 

interest. The investigation has included inspection and testing of the 

company's physical security systems, verification of the company's 

compliance with state and local laws, and a review of the company's 

background and history. Therefore, pursuant to 21 U.S.C. 823, and in 

accordance with 21 CFR 1301.33, the above named company is granted 

registration as a bulk manufacturer of the basic classes of controlled 

substances listed.



    Dated: May 28, 2010.

Joseph T. Rannazzisi,

Deputy Assistant Administrator, Office of Diversion Control, Drug 

Enforcement Administration.

[FR Doc. 2010-13751 Filed 6-7-10; 8:45 am]

BILLING CODE 4410-09-P